CoaguChek®: The Point of Care coagulation monitoring solution from Roche

Your trusted companion for anticoagulation care from the hospital to patients' homes.

Find more products Contact us

Coagulation self-testing can reduce visits to the clinic and improve time in the therapeutic range1-5

Since 1992, CoaguChek® by Roche Diagnostics, has led the way in Point of Care (POC) testing, developing innovative solutions in coagulation monitoring for both professionals and patients alike. As a market leader in POC International Normalized Ratio (INR) monitoring solutions, CoaguChek®, has played a vital role in anticoagulation therapy, particularly for patients on Vitamin K Antagonist (VKA) medications such as warfarin.

Patient Self Testing of INR has emerged as a resounding success story. Patients managed with POC testing achieve a higher time in therapeutic range and fewer values out of range compared with patients treated with usual care.1-3 This results in fewer treatment-related complications,4,5 fewer hospitalizations and emergency department visits,4,5 and improved patient satisfaction.6-8

Despite the advent of Direct Oral Anticoagulants (DOACs), which have become the preferred choice for many patients, there remains a crucial segment for whom DOACs are not suitable. For these patients, CoaguChek® continues to be the cost-effective and proven INR monitoring solution, ensuring reliable and personalized care.

An HCP is sitting in a clinic setting with a patient. Together they are observing the data on a CoaguChek INRange system.

CoaguChek® solutions for the Point of Care

Performed by healthcare professionals immediately at the patient's point of care. CoaguChek® offers reliable and easy-to-use solutions that provide immediate results, allowing treatment decisions to be made promptly.

Featured products

The CoaguChek® INRange system for patient INR value self-testing, gives patients confident control of their VKA therapy for more time in therapeutic range.
The CoaguChek® Pro II system, for Point of Care coagulation testing, measures prothrombin time and activated partial thromboplastin in whole blood.
The CoaguChek® XS provides quantitative prothrombin time testing for the monitoring of warfarin therapy, giving fast and reliable results anywhere at any time.
Find more products

You might be interested in

Contact us

Do you have questions about our products or services? We’re here to help. Contact a Roche representative in your region.

Contact us

References

  1. Harrison et al. (2015). Int J Pharm Pract. 23, 173-181.
  2. Okuyama et al. (2014). Circ J. 78, 1342-1348.
  3. Mearns et al. (2014). Thromb J., 12:14.
  4. Karlsson. (2016). BMJ Qual Improv Rep. 5, pii.w4421.
  5. Kong et al. (2008). Ann Hematol. 87, 905-910.
  6. Chan et al. (2006). Br J Clin Pharmacol. 62, 601-609.
  7. Thompson et al. (2009). Pharm Pract (Granada) 7, 213-217.
  8. Wurster & Doran. (2006). Dis Manag. 9, 201-209.